-
-
-
-
-
-
-
ADMA Biologics Investors Should Contact Block & Leviton By August 10th to Lead Class Action Lawsuit
-
-
-
-
-
-
-
ADMA Biologics refutes short seller allegations about products
-
-
-
-
-
-
-
ADMA Biologics (ADMA) Tops Q4 EPS by 1c ; Offers Guidance
-
-
-
-
-
-
-
ADMA Biologics (ADMA) Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process
-
-
-
-
-
-
-
Options with decreasing option implied volatility: MNKD AEHR AUR GME IRBT ADMA CONY
-
-
-
-
-
-
-
Mizuho Healthcare Desk Distributes Comments on ADMA Biologics (ADMA) Weakness Post Call, Shares Down ~20%
-
-
-
-
-
-
416,697 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

